PNPLA3 and steatosis: In line with these data, we found that the effect of PNPLA3 148M/M on fibrogenesis was more evident in subjects with grade 2–3 steatosis, and in those with other conditions favoring hepatocellular lipid accumulation, such as infection with genotype 3 and overweight.